Work

P-357 Cyclooxygenase-2 (COX-2) inhibition in advanced non-small cell lung cancer (NSCLC): preliminary results of a phase II trial (THO-0054)

Year: 2003

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(03)92325-7

Authors: Iidiko Csiki, Adriana Gonzalez, David P. Carbone, Shiva Gautam, Alan Sandler, Norma Campbell, Ben Garcia, Jason Morrow, David H. Johnson

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1966849936

Cites:

Cited by: 5

Related to: 10